LMB In The News

Business Weekly reports that Sortera Bio, an LMB spinout company, has attracted backers for a £7.5m pre-seed round to power AI models for drug discovery. The round was led by Cambridge Innovation Capital (CIC) with participation from AstraZeneca and BioNTech. More…

Business Weekly reports that Constructive.Bio, an LMB spinout company based on Jason Chin’s research, now holds the exclusive licence to ‘tRNA Display’ technology. The company can start a full commercial rollout of its platform – enabling next-gen synthetic protein engineering applications for pharma, agriculture and advanced materials. More…

Anne Bertolotti, Group Leader and Joint Head of the LMB’s Neurobiology Division, has been announced as the 2025 recipient of the Jubilee Award Lecture from the International Union of Biochemistry and Molecular Biology (IUBMB) in recognition of her research on protein quality control mechanisms. More…

Emmanuel Derivery, Group Leader in the LMB’s Cell Biology Division, speaks to the Journal of Cell Science on the motivations behind his career as a researcher studying fundamental cellular processes, his international collaborations in the field of protein design, and the advice he’d give to scientists looking to start their own research groups. More…

The History Hour by BBC World Service have covered Max Perutz’s Nobel Prize winning work to determine the structure of haemoglobin. Their coverage includes archival interviews with Max himself, plus contributions from Alan Fersht, emeritus scientist in the LMB’s PNAC Division and a contemporary of Max’s. More…

Kelly Nguyen, Group Leader in the LMB’s Structural Studies Division, speaks to the Journal of Cell Science on several topics, including the inspirations behind her career so far, the value of mentorship, and her passion for martial arts. More…